undamentalytics Newsletter

Contreras Jaime: insider trades

Officer at Abbott Laboratories. No open-market purchases and 22 sales not made under a pre-set plan, reported from November 1, 2013 to March 3, 2020.

What happened after Contreras Jaime’s sales?

After their sales, the shares moved +9.0% against the index over 12 months on average (a negative figure means selling was the right call); 32% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Contreras Jaime: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 22 +3.7% +3.4% 27% 8 1.74 0.12 No reliable evidence
Sales, 12 months after the report 22 +9.0% +7.6% 32% 8 1.89 0.10 No reliable evidence
Sales, 12 months after the trade 22 +10.0% +5.8% 27% 8 1.98 0.089 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Abbott Laboratories ABT Senior Vice President022November 1, 2013March 3, 2020

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 3, 2020March 2, 2020 ABT Sale $155,858 +11.4%+20.9%+25.1%
April 29, 2019April 25, 2019 ABT Sale $5,791,487 +8.6%+16.1%+23.5%
April 24, 2019April 22, 2019 ABT Sale $67,124 +9.9%+23.5%+32.3%
March 4, 2019March 1, 2019 ABT Sale $983,317 −1.6%−7.6%−6.8%
February 1, 2019January 30, 2019 ABT Sale $12,421,990 +1.4%+0.4%+1.6%
August 31, 2018August 29, 2018 ABT Sale $6,393,671 +14.3%+25.3%+26.9%
August 31, 2018August 29, 2018 ABT Sale $4,295,449 +14.3%+25.3%+26.9%
April 25, 2018April 23, 2018 ABT Sale $50,397 +4.0%+21.4%+21.0%
March 2, 2018March 1, 2018 ABT Sale $375,379 +3.5%+27.2%+29.8%
September 26, 2017September 22, 2017 ABT Sale $2,738,603 +3.3%+24.3%+19.9%
April 4, 2017March 31, 2017 ABT Sale $34,239 +7.2%+21.5%+23.0%
March 2, 2017February 28, 2017 ABT Sale $592,208 +0.5%+19.9%+19.6%
April 1, 2016March 31, 2016 ABT Sale $19,304 −8.3%−8.7%−8.1%
March 2, 2016February 29, 2016 ABT Sale $413,441 −3.7%−2.4%−5.5%
April 2, 2015March 31, 2015 ABT Sale $10,586 +8.0%−7.5%−9.4%
March 3, 2015March 2, 2015 ABT Sale $435,954 +3.2%−12.6%−10.2%
February 18, 2015February 18, 2015 ABT Sale $19,568 +4.1%−8.8%−8.9%
November 26, 2014November 25, 2014 ABT Sale $2,274,042 +3.9%+0.3%+1.9%
November 12, 2014November 10, 2014 ABT Sale $275,199 +1.2%−0.5%+1.7%
March 4, 2014March 3, 2014 ABT Sale $318,175 −2.9%+7.6%+6.0%
February 19, 2014February 18, 2014 ABT Sale $24,194 −1.0%+7.6%+5.6%
November 1, 2013October 30, 2013 ABT Sale $934,792 −0.8%+4.6%+5.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Contreras Jaime traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.